Li Dan, Li Yujuan, Yang Shengjie, Zhang Xiaonan, Cao Yu, Zhao Ran, Zhao Yixi, Jin Xiao, Lu Jing, Wang Xinyue, Wang Qiutao, Liu Longtao, Wu Min
Guang'an Men Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
The Dongfang Hospital of Beijing University of Chinese Medicine, Beijing, China.
Front Pharmacol. 2025 Mar 3;16:1515485. doi: 10.3389/fphar.2025.1515485. eCollection 2025.
Atherosclerosis is a widely studied pathophysiological foundation of cardiovascular diseases. Inflammation and dyslipidemia are risk factors that promote the formation of atherosclerotic plaques. The gut microbiota and their metabolites are considered independent risk factors for atherosclerosis. Polydatin combined with hawthorn flavonoids, as the extracts of . and , have shown excellent cardiovascular protective effects. However, the underlying mechanism requires further investigation. Our study aimed to explore the anti-atherosclerotic mechanism through gut microbiota and their metabolites.
ApoE mice were fed either a normal-chow diet or a high-fat diet. The polydatin combined with hawthorn flavonoids group received varied doses of polydatin and hawthorn flavonoids: a high dose (polydatin 200 mg/kg daily; hawthorn flavonoids 100 mg/kg daily), a medium dose (polydatin 100 mg/kg daily; hawthorn flavonoids 50 mg/kg daily), and a low dose (polydatin 50 mg/kg daily; hawthorn flavonoids 25 mg/kg daily). The control and model groups were administered distilled water (0.2 mL daily). The experiment lasted for 24 weeks.
Polydatin combined with hawthorn flavonoids administration significantly reduced lipid and inflammatory cytokine levels, meanwhile, the atherosclerotic lesions in a high-fat diet-induced ApoE mice were significantly decreased. Additionally, polydatin combined with hawthorn flavonoids also inhibited the enhancement of trimethylamine N-oxide (TMAO), trimethylamine (TMA) levels of HFD-induced ApoE mice by regulating the expression of hepatic flavin-containing enzyme monooxygenase 3 (FMO3). 16S rRNA sequencing results demonstrated that high-dose polydatin combined with hawthorn flavonoids treatment increased the abundance of , and , and decreased the abundance of . was enriched in the medium-dose polydatin combined with hawthorn flavonoids and simvastatin groups, and was mainly increased in the simvastatin and the low-dose polydatin combined with hawthorn flavonoids groups. According to the metagenetic results, functional annotations also suggested that the biological processes of each group mainly focused on metabolism-related processes. Specifically, polydatin combined with hawthorn flavonoids may regulate the abundance of TMA-producing bacteria (Coriobacteriaceae, , , and ) and related enzymes in glycolipid metabolic pathways to exert an important effect on the prevention of atherosclerosis.
Our results suggested that polydatin combined with hawthorn flavonoids could regulate the glucolipid metabolism-related pathway, attenuate inflammatory cytokine levels, and reduce atherosclerotic plaques by remodeling gut microbiota.
动脉粥样硬化是心血管疾病广泛研究的病理生理基础。炎症和血脂异常是促进动脉粥样硬化斑块形成的危险因素。肠道微生物群及其代谢产物被认为是动脉粥样硬化的独立危险因素。虎杖苷与山楂黄酮作为[具体植物名称1]和[具体植物名称2]的提取物,已显示出优异的心血管保护作用。然而,其潜在机制需要进一步研究。我们的研究旨在通过肠道微生物群及其代谢产物探索抗动脉粥样硬化机制。
给载脂蛋白E(ApoE)小鼠喂食正常饲料或高脂饮食。虎杖苷与山楂黄酮组给予不同剂量的虎杖苷和山楂黄酮:高剂量(虎杖苷每日200mg/kg;山楂黄酮每日100mg/kg)、中剂量(虎杖苷每日100mg/kg;山楂黄酮每日50mg/kg)和低剂量(虎杖苷每日50mg/kg;山楂黄酮每日25mg/kg)。对照组和模型组给予蒸馏水(每日0.2mL)。实验持续24周。
给予虎杖苷与山楂黄酮显著降低脂质和炎性细胞因子水平,同时,高脂饮食诱导的ApoE小鼠的动脉粥样硬化病变显著减少。此外,虎杖苷与山楂黄酮还通过调节肝脏含黄素单加氧酶3(FMO3)的表达,抑制高脂饮食诱导的ApoE小鼠三甲胺N-氧化物(TMAO)、三甲胺(TMA)水平的升高。16S rRNA测序结果表明,高剂量虎杖苷与山楂黄酮治疗增加了[具体菌属1]、[具体菌属2]和[具体菌属3]的丰度,并降低了[具体菌属4]的丰度。[具体菌属5]在中剂量虎杖苷与山楂黄酮及辛伐他汀组中富集,[具体菌属6]主要在辛伐他汀组和低剂量虎杖苷与山楂黄酮组中增加。根据宏基因组结果,功能注释还表明每组的生物学过程主要集中在代谢相关过程。具体而言,虎杖苷与山楂黄酮可能调节产生TMA的细菌(放线菌科、[具体菌属7]、[具体菌属8]和[具体菌属9])的丰度以及糖脂代谢途径中的相关酶,从而对预防动脉粥样硬化发挥重要作用。
我们的结果表明,虎杖苷与山楂黄酮可通过重塑肠道微生物群调节糖脂代谢相关途径,减轻炎性细胞因子水平,并减少动脉粥样硬化斑块。